Recommendation on the Replacement of PCV-10 with PCV-13

CoPI recommends that the PCV-10 is replaced with the PCV-13 in routine immunization and that a surveillance system should be developed to monitor changes in the prevalence of the various serotypes. The committee suggests the following monitoring indicators...

Read more

  Costa Rica
Introduction of Rotavirus Vaccine

The recent results of a cost-effectiveness study for the introduction of the monovalent rotavirus vaccine were presented to representatives of the National Social Security (CCSS) at the ordinary meeting of the CNVE. Further discussions are currently being held to assess the economic feasibility of rotavirus vaccine introduction (procurement and sustainability). 

Read more

  United Kingdom
Meningitis B vaccine extension to all children aged 2 - 11 rejected

MenB vaccination was introduced across the UK last year for babies aged up to 12 months.A petition calling for older children to be vaccinated was signed by more than 800,000 people earlier this year. The JCVI experts concluded it would not be cost-effective to offer the vaccination to children between two and 11, because of the low levels of meningitis B in older children.

Read more

  United States
ACIP recommends not to use LAIV During 2016-17 Flu Season

ACIP voted to recommend that live attenuated influenza vaccine (LAIV; FluMist), which is licensed for use in people ages 2-49 years, should not be used during the 2016-17 flu season.Their decision was based on data showing that the effectiveness of LAIV...

Read more

Focus on

A NITAG for sweden

The first meeting of the Swedish reference group in May 2016 marks the birth of the Swedish NITAG. Until 2015, Sweden was among the 11 countries that did not declare having a NITAG in the WHO-UNICEF Joint Reporting Form. This is no longer the case. Around the table, 12 experts, nominated by relevant Swedish institutions (Child Health Care Units, Medical Products Agency, The National Board of Health and Welfare, The Swedish Association of Local Authorities and Regions) and professional societies (Clinical Microbiology, Infectious Diseases, General Practice, Pediatrics, School nurses and doctors), and approved by the Public Health Agency, met for the first meeting of this brand new committee. 
Read more
Scientific resource
Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response
WHO / July 2016

This document represents the World Health Organization (WHO) Secretariat position on the use of yellow fever (YF) vaccine in the context of supply shortages in response to the current outbreak in Africa in 2016. The evidence and the proposed recommendations, reflected in this document, has been discussed with YF experts and reviewed by the WHO Strategic Advisory Group of Experts (SAGE) on Immunization. SAGE and the YF experts provided input to this paper. 

Read more

Operational resource
Reducing pain at the time of vaccination: WHO position paper, September 2015
Vaccine / July 2016

This article presents the World Health Organization's (WHO) recommendations for pain mitigation at the time of vaccination from the WHO position paper on reducing pain at the time of vaccination: WHO position paper—September 2015, recently published in the Weekly Epidemiological Record. This position paper summarizes the evidence and integrates information pertaining to the reduction of pain, distress and fear during immunization across all age groups.


Read more

Operational resource
Immunization Costing Workshop: What have a learned, can we do better?
EPIC / July 2016

The EPIC project collected immunization costing and financing data at central, subnational, and facility-level in Benin, Ghana, Uganda, Zambia, Honduras, and Moldova and was notable for its rigor in sample design and comprehensiveness of resource use measurement. The study involved over 300 healthcare facilities in the six countries, the largest immunization costing study of its kind. 
In addition to the new analyses from the EPIC study, the workshop also featured new knowledge from studies across the globe, evaluation of country usage of immunization program cost data, identifying opportunities to improve the design of future studies, and specific focus groups and panel discussions to better understand the need of stakeholders in implementing and expanding immunization programs. 
Download all presentation materials

Read more

Iria Preza
Secretariat of the NITAG of Albania
A Global NITAG Network is benefitial because it consolidates the position of the albanian NITAG within decision-makers and governmental structures
Read more
  Upcoming events  
25 -29
  25th Meeting of the Technical Advisory Group (TAG) on Immunization and Vaccine Preventable Diseases

TAG Members will discuss the Region’s progress in achieving the goals of the Regional Framework for Implementation of the Global Vaccine Action Plan. Recommendations will be made for the Western Pacific Regional Office of the World Health Organization and Member States. 

Organized by WHO WPRO
Manila, the Philippines
Read more
17 - 22
  28th international congress of pediatrics

This year’s conference theme, “Community, Diversity, Vitality,” reflects both the host city and the scope of the scientific program.

Organized by the International Pediatric Association (IPA)
Vancouver, Canada
Read more
4 - 7
  10th vaccine congress

the congress will bring together leading experts from all over the world to share the latest cutting-edge discoveries in the field. Join us in Amsterdam next September to hear top-notch invited speakers present state-of-the-art lectures in the field of vaccinology, and to have the opportunity to share and present your own research, as well as form new relationships with potential collaborators!

Organized by Vaccine
Amsterdam, the Netherlands
Read more
  Previous events  
11 - 12
  Global nitag network meeting

For the first time, representatives of NITAGs from all WHO regions gathered together to discuss collaboration between themselves.

Organized by HPID Center
Les pensières, Veryier-du-lac
Read more
6 -10
7th South-East Asia Region Immunisation Technical Advisory Group

During the meeting, and for the first time in such a meeting, participants received an update from each country NITAG chair/Representative of the Chair on the progress of GVAP implementation in their countries. The WHO SEARO shared a report on the progress, the Region made since 2008 in the establishment of NITAGs in the Region. 

Organized by WHO SEARO
New Delhi, India
Read more
18 - 19
  orientation workshop for members of the Zimbabwe NITAG

Following a meeting on NITAGs recommended modes of operations organised by WHO AFRO and partner in Brazzaville in May 2015,  Zimbabwe NITAG undertook an internal assessment and decided to review its membership.

Organized by SIVAC & WHO AFRO
Harare, Zimbabwe
Read more
Copyright © 2015 Nitag Resource Center
Unsubscribe from this list - Change subscription preferences

This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Agence de Médecine Préventive · 164 rue de vaugirard · Paris 75015 · France

Email Marketing Powered by MailChimp